TLR3 inhibitors (University of Colorado)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTLR3 inhibitors (University of Colorado)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 3 antagonists
TargetsToll like receptor 3
Therapy Area/IndicationsInflammationAutoimmune DiseasesCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Colorado SystemUniversity Of Colorado
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A